Department of Medicine
Sara Kalantari’s interests focus on the management of advanced heart failure patients and invasive hemodynamics. One of her research projects is an investigation of the invasive hemodynamic synergistic effects of beta-blockade in patients receiving the drug milrinone. The results were presented at the International Society for Heart and Lung Transplantation in 2017. She is currently working on an industry-funded research study that examines the effects of sacubitril/valsartan on physiological and functional parameters for heart failure patients with reduced ejection fraction.
Kalantari received her bachelor’s degree in biology from the University of Chicago and her MD from the Pritzker School of Medicine. She completed her internal medicine residency training at Brigham and Women’s Hospital and then returned to the University of Chicago for cardiology and advanced heart failure fellowships.